# The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients

> **NCT03819322** · PHASE2 · COMPLETED · sponsor: **Fernanda P Silveira, MD, MS** · enrollment: 5 (actual)

## Conditions studied

- Liver Transplant
- Hepatitis C

## Interventions

- **DRUG:** sofosbuvir/velpatasvir

## Key facts

- **NCT ID:** NCT03819322
- **Lead sponsor:** Fernanda P Silveira, MD, MS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-15
- **Primary completion:** 2025-03-17
- **Final completion:** 2025-03-17
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2026-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03819322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03819322, "The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03819322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*